These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Overexpression of her-2/neu in human prostate cancer and benign hyperplasia. Gu K; Mes-Masson AM; Gauthier J; Saad F Cancer Lett; 1996 Feb; 99(2):185-9. PubMed ID: 8616823 [TBL] [Abstract][Full Text] [Related]
7. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues. Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635 [TBL] [Abstract][Full Text] [Related]
9. Expression of NEU/HER-2 oncoprotein (p185neu) in prostate tumors: an immunohistochemical study. Giri DK; Wadhwa SN; Upadhaya SN; Talwar GP Prostate; 1993; 23(4):329-36. PubMed ID: 7505056 [TBL] [Abstract][Full Text] [Related]
10. Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate. Kirschenbaum A; Klausner AP; Lee R; Unger P; Yao S; Liu XH; Levine AC Urology; 2000 Oct; 56(4):671-6. PubMed ID: 11018637 [TBL] [Abstract][Full Text] [Related]
11. Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer. Häussler O; Epstein JI; Amin MB; Heitz PU; Hailemariam S Hum Pathol; 1999 Sep; 30(9):1077-86. PubMed ID: 10492043 [TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical analysis with anti-cytokeratin antibody in the prostatic epithelium]. Yamanaka Y; Ishida H; Okada K; Nemoto N Nihon Hinyokika Gakkai Zasshi; 2001 Jul; 92(5):545-53. PubMed ID: 11517564 [TBL] [Abstract][Full Text] [Related]
13. Expression of androgen receptor and growth factors in premalignant lesions of the prostate. Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433 [TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia. Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate. Tamboli P; Amin MB; Xu HJ; Linden MD Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470 [TBL] [Abstract][Full Text] [Related]
16. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis. Sinha AA; Gleason DF; Staley NA; Wilson MJ; Sameni M; Sloane BF Anat Rec; 1995 Mar; 241(3):353-62. PubMed ID: 7538734 [TBL] [Abstract][Full Text] [Related]
17. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707 [TBL] [Abstract][Full Text] [Related]
18. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer. Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240 [TBL] [Abstract][Full Text] [Related]
19. Decreased immunoexpression of prostate inhibin peptide in prostatic carcinoma: a study with monoclonal antibody. Zhang PJ; Driscoll DL; Lee HK; Nolan C; Velagapudi SR Hum Pathol; 1999 Feb; 30(2):168-72. PubMed ID: 10029444 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer. Sadasivan R; Morgan R; Jennings S; Austenfeld M; Van Veldhuizen P; Stephens R; Noble M J Urol; 1993 Jul; 150(1):126-31. PubMed ID: 7685420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]